Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), announce that the companies and their advisors have entered into negotiations for an acquisition to better compete in the rapidly changing global AI-driven healthcare industry. Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas.
Read the full article: Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting //
Source: https://www.prnewswire.com/news-releases/avant-technologies-and-ainnova-tech-begin-acquisition-talks-ahead-of-fda-pre-submission-meeting-302452280.html